Evidence map›Paper›PMID 24603341›Full record

Trial reportGenomics

exomeSuite: Whole exome sequence variant filtering tool for rapid identification of putative disease causing SNVs/indels.

B Maranhao, P Biswas, J L Duncan, K E Branham, G A Silva, M A Naeem, S N Khan, S Riazuddin, J F Hejtmancik, J R Heckenlively and 3 more

Abstract readClinical Trial
In one paragraph

Trial report in Genomics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

B MaranhaoDepartment of Ophthalmology, University of California, San Diego, UC Jacobs Retina Center, 9415 Campus Point Drive, La Jolla, CA 92037-0946, USA; Department of Bioengineering, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA. Electronic address: bmaranha@ucsd.edu.
P BiswasDepartment of Ophthalmology, University of California, San Diego, UC Jacobs Retina Center, 9415 Campus Point Drive, La Jolla, CA 92037-0946, USA. Electronic address: pbiswas@ucsd.edu.
J L DuncanDepartment of Ophthalmology, University of California San Francisco, San Francisco, CA 94143, USA. Electronic address: duncanj@vision.ucsf.edu.
K E BranhamDepartment of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Electronic address: haag@med.umich.edu.
G A SilvaDepartment of Ophthalmology, University of California, San Diego, UC Jacobs Retina Center, 9415 Campus Point Drive, La Jolla, CA 92037-0946, USA; Department of Bioengineering, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA; Neurosciences Graduate Program, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA. Electronic address: gsilva@ucsd.edu.
M A NaeemNational Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan.
S N KhanNational Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan.
S RiazuddinNational Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan.
J F HejtmancikOphthalmic Genetics and Visual Function Branch, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: f3h@helix.nih.gov.
J R HeckenlivelyDepartment of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Electronic address: jrheck@umich.edu.
S A RiazuddinNational Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan; The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
P L LeeDepartment of Ophthalmology, University of California, San Diego, UC Jacobs Retina Center, 9415 Campus Point Drive, La Jolla, CA 92037-0946, USA. Electronic address: plee@scripps.edu.
R AyyagariDepartment of Ophthalmology, University of California, San Diego, UC Jacobs Retina Center, 9415 Campus Point Drive, La Jolla, CA 92037-0946, USA. Electronic address: rayyagari@ucsd.edu.

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007198 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHI, NEIL C, INSEL, PAUL A · 1985 to 2024
$29.3M
Inherited Ocular DiseasesZIAEY000272 · NEI · NATIONAL EYE INSTITUTE · PI HEJTMANCIK, JAMES F. · 2009 to 2025
$27.0M
Vision BiostatisticsP30EY022589 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Derek Stuart Welsbie · 2012 to 2026
$10.3M
Molecular Basis of Hereditary Retinal DegenerationsR01EY021237 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AYYAGARI, RADHA · 2011 to 2020
$5.6M
NEI NIH HHS P30 EY022589NEI NIH HHS R01 EY021237NIGMS NIH HHS T32 GM007198
6 · The paper itself

Abstract

Exome and whole-genome analyses powered by next-generation sequencing (NGS) have become invaluable tools in identifying causal mutations responsible for Mendelian disorders. Given that individual exomes contain several thousand single nucleotide variants and insertions/deletions, it remains a challenge to analyze large numbers of variants from multiple exomes to identify causal alleles associated with inherited conditions. To this end, we have developed user-friendly software that analyzes variant calls from multiple individuals to facilitate identification of causal mutations. The software, termed exomeSuite, filters for putative causative variants of monogenic diseases inherited in one of three forms: dominant, recessive caused by a homozygous variant, or recessive caused by two compound heterozygous variants. In addition, exomeSuite can perform homozygosity mapping and analyze the variant data of multiple unrelated individuals. Here we demonstrate that filtering of variants with exomeSuite reduces datasets to a fraction of a percent of their original size. To the best of our knowledge this is the first freely available software developed to analyze variant data from multiple individuals that rapidly assimilates and filters large data sets based on pattern of inheritance.

Indexed as

Datasets as TopicExomeINDEL MutationPolymorphism, Single NucleotideSoftwareAllelesDNA Mutational AnalysisFemaleGenetic Diseases, InbornGenome-Wide Association StudyHeterozygoteHomozygoteHumansMalePedigreeExomeFilteringHomozygosity mappingMendelian diseaseSoftware

Identifiers

PMID24603341
PMCPMC4146529

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.